Cargando…

Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity

A growing number of youth suffer from obesity and in particular severe obesity for which intensive lifestyle intervention does not adequately reduce excess adiposity. A treatment gap exists wherein effective treatment options for an adolescent with severe obesity include intensive lifestyle modifica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Gitanjali, Fox, Claudia K., Kelly, Aaron S., Jastreboff, Ania M., Browne, Allen F., Browne, Nancy T., Pratt, Janey S. A., Bolling, Christopher, Michalsky, Marc P., Cook, Stephen, Lenders, Carine M., Apovian, Caroline M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449849/ https://www.ncbi.nlm.nih.gov/pubmed/30677262 http://dx.doi.org/10.1002/oby.22385

Ejemplares similares

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

Obesity Pillars roundtable: Metabolic and bariatric surgery in children and adolescents
por: Cuda, Suzanne E., et al.
Publicado: (2022)

Clinical Challenge: Patient With Severe Obesity BMI 46 kg/m(2)
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

Combined GLP-1 Receptor Agonist and Amylin Analogue Pharmacotherapy to Treat Obesity Comorbid With Type 1 Diabetes
por: Wong, Gunther, et al.
Publicado: (2023)

Shape-Up and Eat Right Families Pilot Program: Feasibility of a Weight Management Shared Medical Appointment Model in African-Americans With Obesity at an Urban Academic Medical Center
por: Srivastava, Gitanjali, et al.
Publicado: (2018)

Nutritional and activity recommendations for the child with normal weight, overweight, and obesity with consideration of food insecurity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022
por: Browne, Nancy T., et al.
Publicado: (2022)

Pharmacotherapy for Obesity
por: Joo, Jong Kil, et al.
Publicado: (2014)

Obesity pharmacotherapy: current status
por: Kumar, Parveen, et al.
Publicado: (2015)

Obesity Treatment – Is Pharmacotherapy the Answer?
por: Rangbulla, Aditya Kumar
Publicado: (2020)

Neural Correlates of Stress- and Food Cue–Induced Food Craving in Obesity: Association with insulin levels
por: Jastreboff, Ania M., et al.
Publicado: (2013)

Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
por: Veerman, J. Lennert, et al.
Publicado: (2011)

Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne, et al.
Publicado: (2022)

Effects of Pharmacotherapy for the Treatment of Obesity in an Urban, Safety-Net Population
por: Kim, Eric K, et al.
Publicado: (2023)

Pharmacotherapies for Obesity: Past, Current, and Future Therapies
por: Ioannides-Demos, Lisa L., et al.
Publicado: (2011)

Obesity Pharmacotherapy: Current Perspectives and Future Directions
por: Misra, Monika
Publicado: (2013)

Obesity Pharmacotherapy in Patients With Type 2 Diabetes
por: Kahan, Scott, et al.
Publicado: (2017)

Current Long-Term Pharmacotherapies for the Management of Obesity
por: Kim, Bo-Yeon, et al.
Publicado: (2020)

GLP-1 physiology informs the pharmacotherapy of obesity
por: Drucker, Daniel J.
Publicado: (2021)

Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
por: Lim, Francesca, et al.
Publicado: (2023)

The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
por: Lee, Minyi, et al.
Publicado: (2019)

Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19
por: Kang, Yu Mi, et al.
Publicado: (2021)

The use of virtual visits for obesity pharmacotherapy in patients with overweight or obesity compared with in‐person encounters
por: Griebeler, Marcio L., et al.
Publicado: (2022)

Management of diabetes across the course of disease: minimizing obesity-associated complications
por: Apovian, Caroline M
Publicado: (2011)

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022)

Quantifying Energy Intake Changes during Obesity Pharmacotherapy
por: Göbel, Britta, et al.
Publicado: (2014)

The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA
por: Baum, Charles, et al.
Publicado: (2015)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Pharmacotherapy for chronic obesity management: a look into the future
por: Abdel-Malek, Mariana, et al.
Publicado: (2023)

The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and Discussion
por: Fox, Claudia K., et al.
Publicado: (2018)

Diagnostic challenge: A pediatric patient with severe obesity and complications of imminent death
por: Srivastava, Gitanjali
Publicado: (2023)

Clinical review: Implementation of trauma informed care to optimally impact the treatment of childhood obesity
por: Williams, Dominique R., et al.
Publicado: (2022)

Review of upstream social factors contributing to childhood obesity
por: Williams, Dominique R., et al.
Publicado: (2022)

Letter to the Editor of ObesityPillars from the Obesity Medicine Fellowship Council
por: Ahn, Yoon Ji, et al.
Publicado: (2023)

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy
por: Merlino, Dante J., et al.
Publicado: (2014)

Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
por: Anandhakrishnan, Ananthi, et al.
Publicado: (2016)

Proportional Feedback Control of Energy Intake during Obesity Pharmacotherapy
por: Hall, Kevin D., et al.
Publicado: (2017)

LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
por: Liu, Dan, et al.
Publicado: (2022)

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
por: Chakhtoura, Marlene, et al.
Publicado: (2023)

Leptin Is Associated With Exaggerated Brain Reward and Emotion Responses to Food Images in Adolescent Obesity
por: Jastreboff, Ania M., et al.
Publicado: (2014)

Weight Considerations in Pharmacotherapy for Type 2 Diabetes
por: Cheng, Vicky, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9jnknq4etm8h34pjq6rvab1ubn